Area of research
Ophthalmology · Molecular Biology
Research interest
Research interests include Retinal Diseases and Treatments, Retinal Development and Disorders, Glaucoma and retinal disorders, and Ubiquitin and proteasome pathways.
Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy
Profiling disease-selective drug targets: From proteomics to ligandomics
Neurovascular regulation in diabetic retinopathy and emerging therapies
Selectively targeting disease‐restricted secretogranin III to alleviate choroidal neovascularization
Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety
Secretogranin III as a novel target for the therapy of choroidal neovascularization
Function-first ligandomics for ocular vascular research and drug target discovery
Ligandomics: a paradigm shift in biological drug discovery
Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy
Secretogranin III: a diabetic retinopathy-selective angiogenic factor
Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease